These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24860149)

  • 1. VEGF-dependent and PDGF-dependent dynamic neurovascular reconstruction in the neurohypophysis of adult mice.
    Furube E; Mannari T; Morita S; Nishikawa K; Yoshida A; Itoh M; Miyata S
    J Endocrinol; 2014 Jul; 222(1):161-79. PubMed ID: 24860149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Reconstruction of the Perivascular Space in the Adult Mouse Neurohypophysis During an Osmotic Stimulation.
    Nishikawa K; Furube E; Morita S; Horii-Hayashi N; Nishi M; Miyata S
    J Neuroendocrinol; 2017 Feb; 29(2):. PubMed ID: 28072496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-dependent remodeling of chondroitin sulfate proteoglycans extracellular matrix in the hypothalamo-neurohypophysial system.
    Morita S; Oohira A; Miyata S
    Neuroscience; 2010 Apr; 166(4):1068-82. PubMed ID: 20109532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-dependent Notch signalling in the hypothalamic-neurohypophysial system of adult mouse brains.
    Mannari T; Miyata S
    J Neuroendocrinol; 2014 Aug; 26(8):497-509. PubMed ID: 24943269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.
    Wedge SR; Kendrew J; Hennequin LF; Valentine PJ; Barry ST; Brave SR; Smith NR; James NH; Dukes M; Curwen JO; Chester R; Jackson JA; Boffey SJ; Kilburn LL; Barnett S; Richmond GH; Wadsworth PF; Walker M; Bigley AL; Taylor ST; Cooper L; Beck S; Jürgensmeier JM; Ogilvie DJ
    Cancer Res; 2005 May; 65(10):4389-400. PubMed ID: 15899831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor-dependent angiogenesis and dynamic vascular plasticity in the sensory circumventricular organs of adult mouse brain.
    Morita S; Furube E; Mannari T; Okuda H; Tatsumi K; Wanaka A; Miyata S
    Cell Tissue Res; 2015 Mar; 359(3):865-84. PubMed ID: 25573819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
    Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
    Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
    Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix-degrading enzymes tissue plasminogen activator and matrix metalloprotease-3 in the hypothalamo-neurohypophysial system.
    Miyata S; Nakatani Y; Hayashi N; Nakashima T
    Brain Res; 2005 Oct; 1058(1-2):1-9. PubMed ID: 16150423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-dependent continuous angiogenesis in the median eminence of adult mice.
    Morita S; Ukai S; Miyata S
    Eur J Neurosci; 2013 Feb; 37(4):508-18. PubMed ID: 23173692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular signal-regulated kinases and AP-1 mediate the up-regulation of vascular endothelial growth factor by PDGF in human vascular smooth muscle cells.
    Chang HJ; Park JS; Kim MH; Hong MH; Kim KM; Kim SM; Shin BA; Ahn BW; Jung YD
    Int J Oncol; 2006 Jan; 28(1):135-41. PubMed ID: 16327989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Understanding of Structural Reorganization in the Hypothalamic Neurosecretory System.
    Miyata S
    Front Endocrinol (Lausanne); 2017; 8():275. PubMed ID: 29089925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
    Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
    Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin regulation of epithelial colonic proliferation and permeability is mediated by pericryptal platelet-derived growth factor A.
    Miró L; Pérez-Bosque A; Maijó M; Naftalin RJ; Moretó M
    Exp Physiol; 2014 Oct; 99(10):1325-34. PubMed ID: 25085844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
    Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.